Metabolic syndrome components increase endometrial cancer risk
A direct association exists between endometrial cancer risk and individual components of the metabolic syndrome beyond simply being overweight, according to a case-control study.
A direct association exists between endometrial cancer risk and individual components of the metabolic syndrome (MetS) beyond simply being overweight, according to a case-control study of more than 1,200 women in Italy.
Researchers found that women with type 2 diabetes mellitus were more than twice as likely as those without the disease to develop endometrial cancer (odds ratio [OR], 2.18).
In addition, the ORs for developing endometrial cancer were 1.77 for women with hypertension, 1.20 for women with hyperlipidemia, between 1.62 and 2.23 for women who fit various definitions of central obesity, and 3.83 for women with a body mass index (BMI) greater than 30 kg/m2.
Rosato V, Zucchetto A, Bosetti C, et al. Metabolic syndrome and endometrial cancer risk. Ann Oncol. October 11, 2010. Epub ahead of print.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
